Rare
lephants
Screener
Toggle theme
Cadre Holdings, Inc.
CDRE
·
Healthcare, Medical Devices, United States
Analysis
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Total Cash from Operations:
$78.4M
Line Item
Value
% of Total
Capital Expenditures
$4.5M
5.7%
Business Acquisitions
$55.5M
70.9%
Working Capital
$6.9M
8.8%
Net Cash Flow
$11.4M
14.6%
Download CSV
